Although IL-6 levels in sera of MS patients are not elevated in agreement with the resting state of peripheral T cells in MS patients [18], our results highlight a direct relevance of altered IL-6 kinetics to dysregulated immune responses in MS. The gene discussed is IL6; the disease is myeloid sarcoma.